Consistently, mutation of Arg-1625 in SETD2 (R1625C) in ccRCC attenuates the level of H3K36me3 relative to that found in cells expressing the wild-type SETD2. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.